Clinical Trial Update: Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of Technetium Tc-99m Demobesin-4 for imaging in prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Technetium Tc-99m Demobesin-4 (Demobesin-4)

Snippet

Sponsor: Cancer Research UK | Conditions: Prostate Cancer | Phase 1 | Status: TERMINATED